Compared with hormone receptor-positive or HER2-positive breast cancers, TNBC is known for its aggressiveness with larger tumor size, lymph node involvement, higher tumor grade, higher relapse rate of localized TNBC to metastatic TNBC, and a propensity to affect younger patients [3,4,5]. This evidence concerns the gene ERBB2 and neoplasm.